Bayer reported EUR9.92B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Air Liquide EUR 10.93B 561.2M Jun/2026
Akzo Nobel EUR 2.61B 273M Sep/2026
Alcon AG USD 2.36B 423M Sep/2026
Amarin USD 51.48M 113K Dec/2025
Arkema EUR 2.24B 800K Sep/2026
AstraZeneca USD 11.55B 674M Sep/2026
BASF EUR 16.49B 719M Sep/2026
Bayer EUR 9.92B 121M Sep/2026
Beiersdorf EUR 4.19B 32M Jun/2026
Corteva USD 24.49B 20.07B Sep/2026
Covestro EUR 3.24B 5.46B Dec/2025
Essilor EUR 12.52B 568M Jun/2026
Fresenius EUR 5.24B 19M Sep/2026
Fresenius Medical Care EUR 4.55B 229.7M Sep/2026
Genmab DKK 748M 77M Jun/2026
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 6.03B 227M Sep/2026
GRIFOLS EUR 1.65B 101M Sep/2026
Henkel EUR 8.7B 35M Jun/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Johnson Matthey GBP 7.02B 1.81B Jun/2026
Linde USD 6.86B 451M Sep/2026
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.97B 630M Sep/2026
Novartis USD 9.88B 325M Sep/2026
Nutrien USD 5.42B 3.54B Sep/2026
Philips EUR 4.23B 478M Sep/2026
PPG Industries USD 3.7B 154M Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 10.51B 598M Sep/2026
SAP EUR 9.34B 2.11B Sep/2026
Solvay EUR 1.06B 8M Sep/2026
UCB EUR 2.96B 196M Dec/2025
Umicore EUR 27.12B 17.15B Jun/2026
Vinci EUR 32.03B 2.09B Jun/2026